GPX Gasporox AB (publ)
Gasporox AB (publ) engages in the development and commercialization of tunable diode laser absorption spectroscopy technology in Sweden. The company offers instruments, such as GPX1500 vial, GPX1500 film pharma, and GPX1500 film food; linearch machines; VialArch, BottleArch, AutoMAP pharma and food, and CellSpect sensors; and GPX HMI software. It also provides laboratory services, including alpha studies, multi-parameter analysis, batch check, stability studies, and customer defined studies; and IQ/OQ protocols, remote calibration services, training, and customized accessories for the GPX1500. Gasporox AB (publ) was incorporated in 2005 and is based in Lund, Sweden.…
Industry Peers
Scientific & Technical InstrumentsKey Statistics
About Gasporox (STO: GPX)
›
Gasporox (STO: GPX) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Scientific & Technical Instruments industry, part of the Technology sector, and reports about 22 employees.
The shares were at 3.700 SEK on 18 November 2026, down 53.0% over 52 weeks. Its 52-week range is 3.300 SEK to 9.400 SEK: the price is 60.6% below the high and 12.1% above the low.
Its market capitalisation is 36.10M SEK.
Gasporox reports return on equity of -38.8%, an operating margin of -16.9% and revenue down 58.5% year over year.
Its debt exceeds its cash by 7.86M SEK, a debt-to-equity ratio of 0.77. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.